Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

15:01 EDT 16th April 2014 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 21,000+

Wednesday 16th April 2014

EMA Reports Vials of Falsified Herceptin Identified

The European Medicines Agency (EMA) has been informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into th...

Global Predictive Diagnostics Industry

LONDON, April 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Predictive Diagnostics Industryhttp://www.reportbuyer.com/pharma_healthcare/diagnostics/global_predictive_diagnostics_industry.html This report analyzes the worldwide markets for Predictive Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan...

An usual umbilical cord

A male infant was born at term after an uneventful pregnancy with normal antenatal scans. He was noted to be oedematous, with a large umbilical cord that contained a purple, tortuous structure along...

Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

Objective To provide an accurate assessment of complications of pregnancy in women with chronic hypertension, including comparison with population pregnancy data (US) to inform pre-pregnancy and...

UPDATE 1-EU medicines agency warns of stolen Roche cancer drug

LONDON, April 16 (Reuters) - The European Medicines Agency warned on Wednesday that vials of Roche's breast cancer drug Herceptin, thought to have been stolen from hospitals in Italy, have been tampered with and reintroduced into the supply chain.

USMD Holdings, Inc. Combines with Associates in Urology; Dr. Pumphrey and Dr. Walter Join USMD Team

USMD Holdings, Inc. (NASDAQ: USMD), a physician-led integrated health system, announces that USMD Holdings has acquired the assets of Associates in Urology, a Fort Worth-based urology practice group. As a result, Dr. John Pumphrey and Dr. Mi

Cubresa Announces New Compact SPECT Scanner for Preclinical Imaging Research

A Fast and Affordable Way to Add SPECT to an Existing Small Animal CT Scanner Winnipeg, Manitoba (PRWEB) April 16, 2014 Today Cubresa introduced a new compact, affordable SPECT scanner for preclinical research. The scanner attaches to existing small animal CT systems, transforming them into multi-modality molecular imaging systems for disease study, translational research and drug discovery appl...

Duquesne Research, Supported with $1.4 Million NIH Grant, Could Lead to Earlier Cancer Detection

PITTSBURGH, April 16, 2014 /PRNewswire-USNewswire/ -- Duquesne University's newly established biomedical engineering initiative has made an immediate impact, receiving a $1.4 million, five-year grant from the National Institutes of Health's National Cancer Institute to detect, capture and analyze circulating melanoma cells. BME program Director Dr. John Viator, a specialist in medical lasers, wil...

SRI International Announces PDCellX™ Xenograft Tumor Model Services to Accelerate Cancer Drug Research

MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenogr...

Canada’s first top 10 watch list of game-changing health technologies released

Three new cancer drug treatments, five medical devices, and two medical procedures have been selected as Canada’s top 10 new and emerging health technologies by a blue-ribbon panel of experts. The first Top 10 New and Emerging Health Technology Watch List was publicly released at the 2014 CADTH Symposium on April 7th. Over the past

OncoBlog: AACR Eyes Tobacco Control (CME/CE)

SAN DIEGO (MedPage Today) -- The American Association for Cancer Research continued the commemoration of the 50th anniversary of the first Surgeon General's report on health consequences of tobacco with a look back and ahead.

BRIEF-EU medicines agency warns of stolen Roche cancer drug

* European Medicines Agency - informed that vials of cancer medicine Herceptin (Trastuzumab), thought to have been stolen in Italy, have been tampered with and re-introduced under false credentials into supply chain in some countries

ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014, before the market opens. Following the announcement, at 8:30 a.m. Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update....

EU medicines agency warns of stolen Roche cancer drug

LONDON, April 16 (Reuters) - The European Medicines Agency warned on Wednesday that vials of Roche's breast cancer Herceptin, thought to have been stolen from hospitals in Italy, have been tampered with and reintroduced into the supply chain.

Antares Pharma Announces Additional Patent Coverage for OTREXUP

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patents RE44846 and RE44847. These patents are reissued versions of U.S. Patents 7,744,582, and 7,776,015. Tracing back to inventions made in the late 1990’s, the patents capture innovations in the field of auto injectors that originally established Antares Pharma’s position as a...

Cancer Monthly Warns: Actos Not the Only Drug That May Pose Bladder Cancer Risk

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWEB) April 16, 2014 The diabetes drug Actos has made news headlines this week after a jury decided that its manufacturer, Takeda, was responsible for causing bladder cancer in this case. But A...

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

At a press conference during AACR, Dr John Park discussed the findings surrounding the I-SPY 2 trial which identified a neo-adjuvant regimen containing the investigational drug neratinib, which may benefit HER 2 positive breast cancer patients in the...

Foundation Medicine Announces Timing for First Quarter 2014 Financial Results and Conference Call

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company’s first quarter ended March 31, 2014 will be released on Wednesday, May 7, 2014. The management team will host a conference call discussing the company’s financial results and recent developments on Wednesday, May 7, 2014 at 4:30 p.m. ET. The call can be acces...

Oxford Finance and Silicon Valley Bank Expand Existing Senior Credit Facility with Sorrento Therapeutics to $12.5 Million

ALEXANDRIA, Va., April 16, 2014 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, today announced a $7.5 million expansion to an existing $5 million term loan with Sorrento Therapeutics, Inc ("Sorrento"). Proceeds of the loan will be used to advance the development of multip...

Inergetics Scientific/Medical Advisory Board Member Dr. Michelle Sexton Co-authors Important Research in the Cannabis Monograph

NEWARK, N.J., April 16, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today saluted important new research on the science behind the medical benefits of cannabis and its active cannabinoids that Dr. Michelle Sexton, a member of its Scientific/Medical Advisory Board, helped author and review. Dr. Sexton served as co-editor and technical ad...

Statins 'may curb prostate cancer'

Cholesterol-lowering statin drugs may curb the spread of prostate cancer by interfering with the ability of tumour cells to squeeze into bones, research has shown.

Statins 'may curb prostate cancer', suggests lab trial

Cholesterol-lowering statins may curb the spread of prostate cancer by interfering with the ability of tumour cells to squeeze into bones, UK research has shown.

ASCO, ESMO, EORTC, ESO, and UICC Continue Endorsing the WIN Symposium Series in 2014

Five major cancer organizations which have endorsed previous events in the WIN Symposium Series, are also endorsing the WIN 2014 Symposium, to be held in Paris, June 23 - 24. The high scientific level and expected strong impact of this symposium are reflected by endorsements received from ASCO*, ESMO, EORTC, ESO, and UICC. Exceptional agenda featu...

Press Ganey Awards Joanie Abdu Center ‘Guardian of Excellence’ Recognition

Award acknowledges Joanie Abdu Comprehensive Breast Care Center for maintaining 99% patient satisfaction. Youngstown, Ohio (PRWEB) April 16, 2014 Joanie Abdu Comprehensive Breast Care Center was recently named a Guardian of Excellence Award winner for 2013 by Press Ganey Associates Inc. The Guardian of Excellence Award recognizes top-performing healthcare providers that consistently achieved the...

Pyridoxine-doxylamine drug safety data lacking

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research out of St. Michael's Hosp...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement